Diabetes Antibody Standardization Program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Diabetologia

Volumn 51, Issue 5, 2008, Pages 846-852

  Torn C ^a   Mueller, P W ^b   Schlosser, M ^c   Bonifacio, E ^d   Bingley, P J ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adjusted sensitivity; AUC; GAD autoantibodies; IA 2 autoantibodies; Islet autoantibodies; Prediction; Sensitivity; Specificity

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; IA 2 AUTOANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH PROGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MOLECULAR CLONING; PANCREAS ISLET; PRIORITY JOURNAL; ROC CURVE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; DIABETES MELLITUS; GLUTAMATE DECARBOXYLASE; HUMANS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 41849115906     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0967-2     Document Type: Article

References (18)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
2. Turner R, Stratton I, Horton V et al (1997) Autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293
3. The European Nicotinamide Diabetes Intervention Trial group (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
4. Hagopian WA, Lernmark AKE, Rewers MJ et al (2006) TEDDY-The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann N Y Acad Sci 1079:320-326
5. Bottazzo GF, Gleichmann H (1986) Immunology and Diabetes Workshops: report of the first international workshop on standardisation of cytoplasmic islet cell antibodies. Diabetologia 29:125-126
6. Bonifacio E, Boitard C, Gleichmann H et al (1990) Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurements in 41 assays. Diabetologia 33:731-736
7. Verge CF, Stenger D, Bonifacio E et al (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
8. Mire-Sluis AR, Gaines Das R, Lernmark A, Participants of the study (2000) The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 43:1282-1292
9. Bingley PJ, Bonifacio E, Mueller PW, Participating Laboratories (2003) Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136
10. Bonifacio E, Cobain TJ, Dawkins RL et al (1988) Comparison and standardization of measurement of anti-acetylcholine receptor antibody between laboratories. Autoimmunity 1:59-66
11. Stern M, Working Group on Serologic Screening for Celiac Disease (2000) Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr 31:513-519
12. Hagen EC, Andrassy K, Chernok E et al (1993) The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 159:1-16
13. Chan EK, Fritzler MJ, Wiik A et al (2007) IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases. AutoAbSC.Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 6:577-580
14. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H, Participating laboratories (1992) Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the fourth international workshop on the standardization of insulin autoantibody measurement. J Clin Endocrinol Metab 74:1040-1044
15. Dittler J, Seidel D, Schenker M, Ziegler AG (1998) GADIA2-combi determination as first line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47:592-597
16. Seissler J, Morgenthaler NG, Achenbach P et al (1996) Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356
17. Bonifacio E, Genovese S, Braghi S et al (1995) Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822
18. Achenbach P, Schlosser M, Williams AJK et al (2007) Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes antibody standardization program. Clin Immunol 122:85-90